The Peruvian Ministry of Health’s Directorate General of Medicines, Supplies, and Drugs (Digemid) unveiled a new platform aimed at enhancing the dissemination of pharmaceutical research. This initiative provides local researchers with a dedicated space to publish their scientific findings, fostering greater transparency and collaboration within the medical community.
Accessible Publication for Health Professionals
“Revista Ciencia, Política y Regulación Farmacéutica” serves as an open-access, electronic quarterly journal that invites submissions in both Spanish and English. By eliminating publication fees, Digemid encourages a diverse range of contributions from health professionals, academics, and regulatory experts, ensuring widespread accessibility and engagement with the published research.
First Issue Highlights Strategic Collaborations and Safety Reports
The inaugural volume features an editorial on the strategic partnership between Peru and the United Kingdom, aimed at boosting innovation in drug regulation. Additionally, it includes comprehensive safety reports from nine Peruvian pharmacovigilance centers and an analysis of reference product selection criteria used in Latin American therapeutic equivalence studies. A special tribute to Antolín Bedoya Villacorta celebrates his enduring impact on Peruvian pharmacy.
- Digemid’s initiative supports the global standard of peer-reviewed scientific publishing.
- Facilitates international collaboration through bilingual publication options.
- Enhances regulatory practices by integrating regional research findings.
Readers interested in contributing can submit their manuscripts via the official Digemid website, where guidelines are clearly outlined to streamline the submission process. The journal’s commitment to rigorous peer review ensures the quality and reliability of the published articles, positioning it as a cornerstone for pharmaceutical policy and regulation discourse in Peru.
By establishing “Revista Ciencia, Política y Regulación Farmacéutica,” Digemid not only promotes scientific excellence but also reinforces Peru’s role in the global pharmaceutical landscape. This publication empowers researchers to share their insights and advancements, ultimately contributing to the nation’s healthcare improvements and regulatory frameworks.
Researchers and stakeholders in the pharmaceutical sector are encouraged to leverage this platform to further their work and engage with a broader scientific audience, fostering an environment of continuous learning and innovation.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
